NCMM opens call for 1-2 new group leaders

NCMM has opened an international call for applications for one to two new group leaders who will be future scientific leaders in machine learning, tackling fundamental biological questions with potential for application to precision medicine.

NCMM logo

Focus on machine learning applied to fundamental questions in biology

Precision medicine, machine learning, and artificial intelligence are being strengthened in Norway, with a desire to integrate basic and clinical research activities. The Centre aims to strengthen already existing research areas at NCMM and is therefore seeking candidates with a strong background in machine learning to complement ongoing research on rare diseases (immunology, hematology, neurology), cancer, and age-related diseases.

The group leader will be selected using the quality criteria and process of assessment as for recruitment to EMBL Group Leader positions with the focus on scientific excellence and potential to collaborate with existing NCMM group leaders. The successful candidate is expected to initiate a new independent research program with a clear relevance to molecular medicine and disease mechanisms. The research should consolidate existing research within the Centre (see website). The group leader position may be combined with an adjunct position (20%) at Oslo University Hospital, Akershus University Hospital or another national university hospital to facilitate translation and clinical collaboration. An affiliation to another relevant UiO department will also be supported. Furthermore, we expect multi-disciplinary research collaborations with other NCMM research groups and NCMM Associate Investigators, with the internationally recognized biomedical and medical research environment in Oslo as well as with other top Norwegian scientists and within the Nordic EMBL Partnership for molecular medicine.

Strong local life science research and infrastructure and generous start-up package

NCMM enjoys strong links to other life science activities at UiO, including the Oslo Centre for Bioinformatics with its strong research groups within machine learning and AI, the Oslo Centre for Biostatistics and Epidemiology (OCBE) which covers all aspects of biostatistics, and various other research groups strongly involved in life science research. UiO also benefits from its secure HPC services for sensitive data and ELIXIR life science infrastructure support. In addition, there are close ties to Oslo University Hospital, a large university hospital that hosts some of the strongest research environments in Norway within health and the life sciences.

NCMM provides attractive, sustainable support packages for new group leaders of approx. 1.8 million EUR over the first five-year period. This includes salaries of the group leader, a postdoctoral fellow, a doctoral student as well as a technician (total 4 positions), consumables and modern laboratory facilities. The candidates are expected to complement this budget through other national and / or international grants and / or through industrial collaborations. NCMM scientists will be supported by excellent in-house research infrastructures and have access to the local research community’s infrastructures (see technology platforms at University of Oslo and Oslo University Hospital), national infrastructures and international capabilities provided by EMBL.


Application deadline is 18 April 2022.

Learn more and apply.